Request for funding to purchase a DNA sequencer
Active Cooperative Agreement Awarded
- Award ID
- U18FD008902
- Recipient
-
Auburn University UEI DMQNDJDHTDG4
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $62,421
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Auburn University, AL 36849, USA
Award details come from USAspending.gov.
Description
- Abstract
- /summary bacterial diagnostics in veterinary medicine have traditionally relied on culture-based methods. While these methods are widely used, they are time-consuming, often taking days to produce results, and may not accurately represent the complexity of bacterial populations. To address these limitations, we seek funding to acquire a state-of-the-art DNA sequencer (miseq I100 system) to modernize the diagnostic capabilities at auburn university college of veterinary medicine (CVM). This acquisition follows our 2026 purchase of a maldi-TOF machine (maldi biotyper® sirius RUO system), creating a comprehensive suite for advanced bacteriology and mycology services. Direct DNA sequencing offers a rapid alternative to culture, identifying pathogens directly from clinical samples with high precision. This is critical for managing foodborne illnesses, which cause millions of hospitalizations annually in the U.S. Pets are equally vulnerable through contaminated raw foods, making prompt molecular identification essential for outbreak control. By implementing full 16S rrna sequencing, we will enhance diagnostic accuracy for cases where antimicrobial susceptibility testing is not required. Furthermore, this equipment will allow US to sequence and characterize unique clinical isolates, such as the salmonella strains previously identified in our lab as carrying the blasco-1 gene. As auburn university currently lacks a core sequencing facility, this project will establish a vital service for rapid diagnosis and species identification. Ultimately, this technology positions auburn CVM at the forefront of innovative diagnostics. Once the technology is mature, we intend to join VET-lirn sequencing proficiency tests, expanding our capacity to serve as a regional diagnostic resource and contributing to national public health and safety goals.
Quick answers
Who received award U18FD008902?
U18FD008902 was awarded to Auburn University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008902 worth?
$62,421 has been obligated on U18FD008902.
Which agency awarded U18FD008902?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008902, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award